Skip to content

SCHEDULE 13G/AAccepted Nov 14, 4:05 PM ET

Lyell Immunopharma, Inc. SCHEDULE 13G/A

Foresite Capital Fund IV, L.P.

Accepted (ET)

4:05 PM

Nov 14, 2025

Filed

Nov 14, 2025

Documents

1

Size

22.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.